Ezequiel Renzulli

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Placebo Controlled

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Tira Jing Ying Tan, Sarah L Sammons, Young-Hyuck Im, Lilin She, Kelly Mundy, Robert Bigelow, Tiffany A Traina, Carey K Anders, Joe Poh Sheng Yeong, Ezequiel Renzulli, Sung-Bae Kim, Rebecca A Dent
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Tira Jing Ying Tan, Sarah L Sammons, Young-Hyuck Im, Lilin She, Kelly Mundy, Robert Bigelow, Tiffany A Traina, Carey K Anders, Joe Poh Sheng Yeong, Ezequiel Renzulli, Sung-Bae Kim, Rebecca A Dent
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Tira Jing Ying Tan, Sarah L Sammons, Young-Hyuck Im, Lilin She, Kelly Mundy, Robert Bigelow, Tiffany A Traina, Carey K Anders, Joe Poh Sheng Yeong, Ezequiel Renzulli, Sung-Bae Kim, Rebecca A Dent
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)